Integer (ITGR) Competitors

$116.90

+1.22 (+1.05%)

(As of 07/26/2024 ET)

ITGR vs. PODD, TFX, GMED, MASI, IART, ATEC, ATRC, OFIX, SRDX, and ANGO

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Insulet (PODD), Teleflex (TFX), Globus Medical (GMED), Masimo (MASI), Integra LifeSciences (IART), Alphatec (ATEC), AtriCure (ATRC), Orthofix Medical (OFIX), Surmodics (SRDX), and AngioDynamics (ANGO). These companies are all part of the "health care equipment" industry.

Integer vs.

Insulet (NASDAQ:PODD) and Integer (NYSE:ITGR) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, community ranking, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

: Insulet received 337 more outperform votes than Integer when rated by MarketBeat users. Likewise, 66.05% of users gave Insulet an outperform vote while only 63.47% of users gave Integer an outperform vote.
Company Underperform Outperform
Insulet Outperform Votes
714
66.05%
Underperform Votes
367
33.95%
Integer Outperform Votes
377
63.47%
Underperform Votes
217
36.53%
: 99.3% of Integer shares are owned by institutional investors. 0.5% of Insulet shares are owned by company insiders. Comparatively, 2.0% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
: Insulet has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500. Comparatively, Integer has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500.
: Insulet has a net margin of 13.14% compared to Insulet's net margin of 6.01%. Integer's return on equity of 34.06% beat Insulet's return on equity.
Company Net Margins Return on Equity Return on Assets
Insulet 13.14% 34.06% 9.08%
Integer 6.01% 11.25% 5.69%
: In the previous week, Insulet and Insulet both had 21 articles in the media. Integer's average media sentiment score of 0.99 beat Insulet's score of 0.58 indicating that Insulet is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Insulet
9 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Integer
4 Very Positive mention(s)
1 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: Insulet currently has a consensus target price of $239.18, suggesting a potential upside of 23.73%. Integer has a consensus target price of $128.88, suggesting a potential upside of 10.24%. Given Integer's stronger consensus rating and higher possible upside, equities research analysts clearly believe Insulet is more favorable than Integer.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Insulet
0 Sell rating(s)
3 Hold rating(s)

15 Buy rating(s)

0 Strong Buy rating(s)
2.83
Integer
0 Sell rating(s)

2 Hold rating(s)

6 Buy rating(s)

0 Strong Buy rating(s)
2.75
: Insulet has higher revenue and earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Insulet $1.78B 7.60 $206.30M $3.30 58.58
Integer $1.60B 2.45 $90.65M $2.89 40.45

Company	Underperform	Outperform
Insulet	Outperform Votes 714 66.05%	Underperform Votes 367 33.95%
Integer	Outperform Votes 377 63.47%	Underperform Votes 217 36.53%

Company	Net Margins	Return on Equity	Return on Assets
Insulet	13.14%	34.06%	9.08%
Integer	6.01%	11.25%	5.69%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Insulet	9 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	4 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insulet	0 Sell rating(s)	3 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.83
Integer	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.75

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insulet	$1.78B	7.60	$206.30M	$3.30	58.58
Integer	$1.60B	2.45	$90.65M	$2.89	40.45

Summary

Insulet beats Integer on 15 of the 17 factors compared between the two stocks.

Ad Crypto Swap Profits

625,000% Gain

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

Get Integer News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ITGR vs. The Competition

Export to Excel

Metric	Integer	Electromedical equipment Industry	Medical Sector	NYSE Exchange
Market Cap	$3.92B	$3.08B	$5.28B	$18.51B
Dividend Yield	N/A	1.72%	2.79%	3.51%
P/E Ratio	40.45	7.91	156.32	24.86
Price / Sales	2.45	50.08	2,081.72	15.32
Price / Cash	15.68	74.00	35.46	19.61
Price / Book	2.56	3.84	4.94	5.07
Net Income	$90.65M	$85.14M	$111.50M	$976.63M
7 Day Performance	-7.33%	-3.02%	2.71%	1.50%
1 Month Performance	1.86%	-2.75%	11.35%	6.13%
1 Year Performance	34.37%	-2.21%	9.89%	7.83%

Integer Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PODD Insulet	4.8113 of 5 stars 4.81 / 5 stars	$194.23 -0.4%	$239.18 +23.1%	-31.2%	$13.60B	$1.70B	58.86	3,000	Analyst Forecast News Coverage Positive News
TFX Teleflex	4.4395 of 5 stars 4.44 / 5 stars	$222.59 +0.4%	$263.14 +18.2%	-14.0%	$10.48B	$2.97B	35.73	14,500	Upcoming Earnings
GMED Globus Medical	4.7366 of 5 stars 4.74 / 5 stars	$73.40 +1.1%	$73.30 -0.1%	+15.4%	$9.94B	$1.57B	114.69	5,000	Short Interest ↓
MASI Masimo	4.6495 of 5 stars 4.65 / 5 stars	$107.45 +0.6%	$143.57 +33.6%	-9.1%	$5.71B	$2.05B	73.10	5,200
IART Integra LifeSciences	4.0938 of 5 stars 4.09 / 5 stars	$31.53 +0.6%	$32.86 +4.2%	-31.0%	$2.48B	$1.54B	63.06	3,946	Upcoming Earnings Short Interest ↑
ATEC Alphatec	4.5677 of 5 stars 4.57 / 5 stars	$10.90 -1.7%	$20.78 +90.6%	-37.0%	$1.52B	$482.26M	-7.32	839	Upcoming Earnings Analyst Forecast News Coverage
ATRC AtriCure	2.6866 of 5 stars 2.69 / 5 stars	$23.82 -1.4%	$49.78 +109.0%	-61.7%	$1.13B	$399.24M	-29.77	1,200	Upcoming Earnings News Coverage
OFIX Orthofix Medical	0.3286 of 5 stars 0.33 / 5 stars	$16.03 +3.7%	$18.00 +12.3%	-15.8%	$601.61M	$746.64M	-4.74	1,634
SRDX Surmodics	3.9738 of 5 stars 3.97 / 5 stars	$41.78 +0.3%	$50.00 +19.7%	+31.2%	$595.78M	$132.58M	43.98	376	Analyst Forecast News Coverage High Trading Volume
ANGO AngioDynamics	4.6354 of 5 stars 4.64 / 5 stars	$7.13 -0.7%	$12.25 +71.8%	-15.0%	$285.63M	$303.91M	-1.47	760	Short Interest ↓